ARCHIVES

Phase III Trial: Panobinostat Increases PFS by Four Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Onward to 2010? NCI promises faster progress for more money.

May 20, 2005

In Brief: Preyer, Waxman Battle Over Chairmanship Of Health Group; Amos To Head Mas. ACS

January 12, 1979

Rumors Preceded Broder’s Move

December 22, 1994

“Mini-Transplantation” In Testing For Treatment Of Multiple Myeloma

January 25, 2002

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

President Proposes 2.1% Incerase for NIH, 2.4% Increase for NCI, In Year 2000 Budget

February 5, 1999